Propeller Health co-founder Mark Gehring will be speaking at the Founders’ Series meetup hosted by gener8tor on Wednesday, November 6 at 6pm at their office in Madison. Mark Gehring is a co-founder of Propeller Health (formerly Asthmapolis), the leading mobile platform for respiratory health management. Through sensors, mobile apps and services, Propeller Health helps reduce the cost of care while delivering better quality of life for individuals with chronic respiratory disease.
Asthmapolis, maker of the FDA-cleared mobile health solution for asthma and COPD, recently received a second investment from the California HealthCare Foundation (CHCF). Asthmapolis is designed to improve the care of people with asthma and COPD, advance understanding of symptoms and triggers and help them achieve control of these diseases. The CHCF investment in Asthmapolis, which now totals $1,047,000, is directed at helping to support respiratory health management with the underserved in California. Read more about this latest funding here.
Asthmapolis also received the Horizon Award in the 2013 TripleTree iAwards for Connected Health in recognition of its “unique advancements in chronic disease management via connected health.” Read more from the Wisconsin State Journal here.
Asthmapolis has just closed a $5 Million Series A round of funding from The Social+Capital Partnership. Asthmapolis makes an FDA approved â€œsmartâ€ asthma inhaler that helps patients and health providers better monitor, visualize, and understand the behavior of asthma by utilizing a sensor that attaches to an inhaler.
Asthmapolis, on the other hand, is on a mission to hack your inhaler.
Asthmapolis will use the funding to build new sensors that work with other inhaled medications, accelerate plans to secure regulatory clearances in countries outside of the US, and also help market their products. For more information, check out articles on TechCrunch and MobiHealthNews.
Asthmapolis, maker of a smart asthma inhaler, was recently featured in Scientific American. The article focuses on several US cities currently running large scale asthma studies utilizing Asthmapolis’ inhalers that are topped with a small sensor that wirelessly broadcasts when, where and how often the device is used.
Data collected by the sensor can be aggregated to better track and predict asthma outbreaks. This type of smart health tech can be combined with others (like FitBit) to continue to revolutionize how we look at our health. Check out the full article here
We’re smart enough to see the possibilities here in Madison, and accordingly the tech startup scene around iPhone apps is smoldering… Mobile startups are making a dent in the universe from right here, and it’s changing the way that computer professionals who live in Madison are relating to the global technology community.
Asthmapolis and their “smart” asthma inhaler were recently featured in Wired. Asthmapolis helps patients and health providers better monitor the behavior of asthma utilizing a sensor that attaches to an inhaler. The sensor records the time and location of each use, which makes data collection part of the act of using the inhaler. The data can then be analyzed by patients and physicians, and it can also be aggregated to visualize larger patterns. Check out the full Wired article here.
Capital Entrepreneurs member company Asthmapolis recently received FDA clearance for their asthma sensor system. The small GPS enabled sensor attaches to the top of asthma inhalers and captures when and where the inhalor is used. This opens up many possibilities to use the collected data to track inhaler usage, asthma outbreaks, and much more. Check out more info on this here.
CE member company Asthmapolis was recently featured in The Economist magazine. Asthmapolis is creating an inhaler called Spiroscout that can be used by people suffering from asthma. Spiroscout contains a built-in GPS locator that broadcasts the time and location when the inhaler is used. The inhaler data can then be analyzed to determine usage patterns and aggregated to help illuminate more widespread asthma related issues. Be sure the checkout The Economist article.
Asthmapolis was also recently featured in Engadget.
The Asthmapolis team, made up of veteran entrepreneurs Tracy, David Van Sickle, andÂ Mark Gehring, hope to help asthma patients and their doctors learn more about when and where asthma patients use their inhalers.Â There are two main parts to the Asthmapolis system.Â The first part is the Spiroscout, “a device that uses GPS to determine the time and location when an inhaler is used, and then stores or sends that information to a remote server.”Â When an asthma patient uses their inhaler, the Spiroscout system logs the time, place and stores it for later use.
The second part is the mobile dairy.Â By using mobile diary, “you can map and track asthma symptoms, triggers, and your use of rescue and controller medications, and other important events from any phone with a web browser,” write the founders on the Asthmapolis website.Â Users can also choose to receive text messages about location, missed doses and other interesting information that might help them manage their asthma.
The Asthmapolis team added additional functionality with Twilio for the contest so that Asthmapolis users without smart phones can now report about their inhaler uses.Â Union Square Ventures seemed most excited about the SMS capabilities because so much of the world does not have smart phones.Â Adding SMS allows the Asthmapolis team to enter into a much larger market.
As more users adopt the system, Asthmapolis will be able to gather huge amounts of data about where, when and how patients are using their inhalers.Â “From a business perspective, that offersÂ an important long-term defensibility,” writes USV’s Wegner. “We’re looking forward to meeting with Greg and David from Asthmapolis in New York.”
“The Twilio platform is a perfect fit for us as we expand our mobile interfaces,” writes cofounder Greg Tracy, “The fact that the Union Square Ventures team is recognizing our platform is great validation and we’re looking forward to spending some time with them in New York.”